Managing the Complex Needs of PIGT-related MCAHS3
At a Glance
PIGT-related MCAHS3 is managed with an individualized, coordinated plan that addresses seizures, low muscle tone, feeding and swallowing safety, development, and comfort through specialists, therapies, early intervention, and equipment.
Managing PIGT-related MCAHS3 requires a “whole-child” approach. Because the condition affects multiple systems, care is not about a single pill or procedure, but rather a coordinated effort to support your child’s development, safety, and comfort [1][2]. Work with your team to create a clear, individualized rescue-medication and seizure-safety plan.
Managing Seizures (Epilepsy)
Seizures are often the most urgent concern for families. Because the underlying “tether” defect makes the brain’s electrical activity less stable, seizures can be difficult to treat (pharmacoresistant) [1].
- Medication Trials: There is no single “best” drug for PIGT. Doctors may try several anti-seizure medications (ASMs). Some reports show that medications like phenobarbital or clonazepam may help with muscle stiffening (tonic seizures), while others like acetazolamide have been used specifically for brief pauses in breathing during seizures (ictal apnea) [3]. Note: These are examples from individual case reports rather than an established protocol, and choices depend on seizure type, age, and side effects. Sedating medicines can be particularly important to review in a child with hypotonia or breathing concerns.
- Metabolic Trials: In some related genetic conditions, high-dose Vitamin B6 (pyridoxine) or folinic acid has helped, though evidence for PIGT specifically is still emerging [4][5]. These are specialist-directed trials for unexplained epilepsies, not standard therapy for PIGT-CDG. Do not try these supplements independently; high doses of pyridoxine can cause peripheral neuropathy and must be supervised.
- Ketogenic Diet: A specialized high-fat, low-carbohydrate diet, managed by a medical team and dietitian, has shown success in controlling seizures for many children with genetic epilepsies [6]. This is an option considered by a pediatric epilepsy and ketogenic-diet team for selected drug-resistant epilepsy; it is not a routine recommendation.
Supporting Movement and Muscle Tone
Hypotonia (low muscle tone) is nearly universal in PIGT-related conditions [1]. Management focuses on helping your child move safely and preventing secondary issues.
- Physical Therapy (PT): Focuses on “big” movements. PTs work on head and trunk control, helping your child sit or stand with support, and ensuring their joints stay flexible to prevent contractures (permanent tightening of muscles) [7][8].
- Occupational Therapy (OT): Focuses on “small” movements and daily life. OTs help with hand use, play, and specialized seating or equipment that allows your child to interact with their world [7].
- Orthotics and Equipment: Many children benefit from braces (AFOs) to support their ankles or specialized “standers” and “activity chairs” that provide the stability their muscles cannot yet give them [7][9].
Feeding and Nutrition
Severe hypotonia can affect the muscles used for chewing and swallowing. This can lead to dysphagia (difficulty swallowing) and aspiration (when food or liquid accidentally goes into the lungs) [10][11].
- Swallow Studies: Doctors often recommend a swallow study. A clinical feeding assessment followed by VFSS/MBS or FEES when indicated helps evaluate safety [10].
- Nutritional Support: If a child cannot eat enough safely by mouth, a G-tube (gastrostomy tube) may be recommended. This is a small port that allows nutrition to go directly into the stomach, supporting nutrition and hydration [12]. However, a G-tube does not eliminate aspiration from saliva or reflux, and an individualized oral-feeding and aspiration monitoring plan may still be needed.
Your Multidisciplinary Care Team
Because this condition is so rare, you need a team that communicates well. Key specialists often include:
- Pediatric Neurologist: To manage seizures and monitor brain development [1].
- Clinical Geneticist: To explain the PIGT variant and provide guidance on new research [13].
- Pediatric Ophthalmologist: To monitor for vision changes or structural eye issues [14].
- Pediatric Orthopedist: To monitor bone health and spine alignment (scoliosis) [9].
- Therapy Team: PT, OT, and Speech/Feeding therapists who work with your child regularly [7]. Consider adding developmental pediatrics, pulmonology, nutrition, and social work to reflect everyday needs.
Starting Early Intervention
The most important step in management is starting Early Intervention (EI) services as soon as possible. These programs provide therapies in your home or at a center and are designed to take advantage of the brain’s “plasticity”—its ability to learn and adapt—during the earliest years of life [7][9]. Your geneticist or pediatrician can provide the referral needed to begin these services.
Common questions in this guide
How are seizures treated in PIGT-related MCAHS3?
Can vitamin B6 or folinic acid help with PIGT-related MCAHS3 seizures?
What therapies help a child with PIGT-related MCAHS3 and low muscle tone?
How are feeding and swallowing problems evaluated in PIGT-related MCAHS3?
Which specialists should be involved in care for PIGT-related MCAHS3?
Why should early intervention start soon after a PIGT-related MCAHS3 diagnosis?
Get notified when new evidence is published on Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics.
Bayat A, Knaus A, Juul AW, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(10)):2216-2223 doi:10.1038/s41436-019-0512-3.
PMID: 30976099 - 2
Case report: Functional analysis of the p.Arg507Trp variant of the PIGT gene supporting the moderate epilepsy phenotype of mutations in the C-terminal region.
Ben Ayed I, Jallouli O, Murakami Y, et al.
Frontiers in neurology 2023; (14()):1092887 doi:10.3389/fneur.2023.1092887.
PMID: 36970549 - 3
Epileptic apnea in a patient with inherited glycosylphosphatidylinositol anchor deficiency and PIGT mutations.
Kohashi K, Ishiyama A, Yuasa S, et al.
Brain & development 2018; (40(1)):53-57 doi:10.1016/j.braindev.2017.06.005.
PMID: 28728837 - 4
PGAP2-Related Hyperphosphatasia-Mental Retardation Syndrome: Report of a Novel Patient, Toward a Broadening of Phenotypic Spectrum and Therapeutic Perspectives.
Saracino A, Totaro M, Politano D, et al.
Neuropediatrics 2024; (55(2)):129-134 doi:10.1055/s-0044-1779613.
PMID: 38365198 - 5
Hyperphosphatasia with mental retardation syndrome 3: Cerebrospinal fluid abnormalities and correction with pyridoxine and Folinic acid.
Messina M, Manea E, Cullup T, et al.
JIMD reports 2023; (64(1)):42-52 doi:10.1002/jmd2.12347.
PMID: 36636587 - 6
Short-term effectiveness and side effects of ketogenic diet for drug-resistant epilepsy in children with genetic epilepsy syndromes.
Muthaffar OY, Alyazidi AS, Alsowat D, et al.
Frontiers in neurology 2024; (15()):1484752 doi:10.3389/fneur.2024.1484752.
PMID: 39359873 - 7
Expanding the clinical and molecular characteristics of PIGT-CDG, a disorder of glycosylphosphatidylinositol anchors.
Lam C, Golas GA, Davids M, et al.
Molecular genetics and metabolism 2015; (115(2-3)):128-140 doi:10.1016/j.ymgme.2015.04.007.
PMID: 25943031 - 8
A recurrent germline mutation in the PIGA gene causes Simpson-Golabi-Behmel syndrome type 2.
Fauth C, Steindl K, Toutain A, et al.
American journal of medical genetics. Part A 2016; (170A(2)):392-402 doi:10.1002/ajmg.a.37452.
PMID: 26545172 - 9
PIGH deficiency can be associated with severe neurodevelopmental and skeletal manifestations.
Tremblay-Laganière C, Kaiyrzhanov R, Maroofian R, et al.
Clinical genetics 2021; (99(2)):313-317 doi:10.1111/cge.13877.
PMID: 33156547 - 10
Silent aspiration: Who is at risk?
Velayutham P, Irace AL, Kawai K, et al.
The Laryngoscope 2018; (128(8)):1952-1957 doi:10.1002/lary.27070.
PMID: 29280496 - 11
Diagnosis and Management of Pediatric Dysphagia: A Review.
Lawlor CM, Choi S
JAMA otolaryngology-- head & neck surgery 2020; (146(2)):183-191 doi:10.1001/jamaoto.2019.3622.
PMID: 31774493 - 12
Neurogenic Dysphagia and Nutrition in Disorder of Consciousness: An Overview with Practical Advices on an "Old" but Still Actual Clinical Problem.
Raciti L, Raciti G, Pulejo G, et al.
Medicines (Basel, Switzerland) 2022; (9(2)) doi:10.3390/medicines9020016.
PMID: 35200759 - 13
Case report of a child bearing a novel deleterious splicing variant in PIGT.
Mason S, Castilla-Vallmanya L, James C, et al.
Medicine 2019; (98(8)):e14524 doi:10.1097/MD.0000000000014524.
PMID: 30813157 - 14
Bilateral anterior segment dysgenesis and peripheral avascular retina with tractional retinal detachment in an infant with multiple congenital anomalies-hypotony-seizures syndrome 3.
Wu F, Goldenberg PC, Mukai S
Ophthalmic genetics 2021; (42(3)):334-337 doi:10.1080/13816810.2021.1888133.
PMID: 33620284
This page is for informational purposes only and does not constitute medical advice. Your child’s neurologist and multidisciplinary care team should guide seizure medicines, supplements, diet, feeding plans, and equipment.